FXTM information and reviews
FXTM
93%
IronFX information and reviews
IronFX
92%
Libertex information and reviews
Libertex
91%
FXCC information and reviews
FXCC
90%
Markets.com information and reviews
Markets.com
89%
FxPro information and reviews
FxPro
88%
EUR/USD
1.1725
BTC/USD
46 960.90
GBP/USD
1.3735
USD/JPY
109.9290
USD/CHF
0.9322
USD/CAD
1.2769
EUR/JPY
128.8945

Dependence on the COVID-19 vaccine


17 November 2020

The current week started with optimism in the stock markets. So the main European and American stock indices show steady growth, thereby indicating an increase in interest in risky assets. As a result, USD is losing ground across the entire market spectrum, and risk currencies such as AUD and NZD have resumed growth.

I would like to draw your attention to the NZD / USD currency pair, the quotes of which came close to the psychological and at the same time strong technical level of 0.6900, since this is the maximum since the beginning of 2019. Moreover, this level kept buyers for five months. As a result, a breakout and subsequent fixation of quotes above it can provoke a strong wave of growth. However, active purchases under this level are not advisable.

Now let's move on to the cryptocurrency market. After a moderate decline in BTC over the weekend, buying activity has increased markedly, thereby allowing the price to return above 16,000. However, the previous maximum has not been updated yet, so it is extremely difficult to exclude the risk of a deeper corrective decline. The first target for buyers is 16800 - the maximum since the end of December 2017.

Shifting to the US trading session, I note moderate optimism in the oil market, which is also due to the general euphoria about the unexpectedly good results of the vaccine trial in the third phase. But before the opening of markets in the United States, demand for US WTI oil remained moderate and even insufficient to overcome the resistance at $41.5 per barrel. Therefore, we should not exclude the risk of a collapse in oil prices below $40.

With all that said, we see an incredibly high dependence on the vaccine. Any statement, both positive and negative, has an incredibly powerful impact on the markets. Serial production of the vaccine and fairly rapid vaccination in the United States and a number of European countries can provide significant support to stock indices and risky currencies, thereby significantly weakening the USD.

#source

Related

US Retail sales and other data has supported Dollar
US Retail sales and other data has supported Dollar

The US Retail sales notably exceeded expectations, adding 0.7% in August vs an expected 0.7% decline. The increase to August last year is an impressive 14.9%...

17 Sep 2021

Geopolitics Fire Up Up and Cryptos Are Booming
Geopolitics Fire Up Up and Cryptos Are Booming

Futures in the United States and Europe are trading lower today as investors are worried about the new security agreement between the U.S., the U.K. and Australia...

16 Sep 2021

UK inflation surges, stocks struggle
UK inflation surges, stocks struggle

European markets flat at the open this morning as UK inflation surged to a record high in August and Chinese economic data was soft. China’s retail sales fell to...

15 Sep 2021

Gold is anxiously waiting for the US inflation data
Gold is anxiously waiting for the US inflation data

Gold, hovering around $1790 since last Thursday, might take an even harder hit. The bears are waiting for a good signal to launch an attack. It is now holding it below significant levels...

14 Sep 2021

Here Is Why Stock Futures Are Trading Lower
Here Is Why Stock Futures Are Trading Lower

Despite a week of doom and gloom in the stock markets, futures in the United States are still trading lower. Since February, the S&P 500 has been on its longest...

13 Sep 2021

Fintech - too big to be?
Fintech - too big to be?

Two of the world’s largest economies are in sync with pressure on their fintech giants. Access to user data and the growth of ecosystems have effectively...

13 Sep 2021


Editors' Picks

OctaFX information and reviews
OctaFX
86%
HotForex information and reviews
HotForex
85%
XM information and reviews
XM
80%
FXCM information and reviews
FXCM
79%
Vantage FX information and reviews
Vantage FX
78%
Moneta Markets information and reviews
Moneta Markets
77%

© 2006-2021 Forex-Ratings.com

The usage of this website constitutes acceptance of the following legal information.
Any contracts of financial instruments offered to conclude bear high risks and may result in the full loss of the deposited funds. Prior to making transactions one should get acquainted with the risks to which they relate. All the information featured on the website (reviews, brokers' news, comments, analysis, quotes, forecasts or other information materials provided by Forex Ratings, as well as information provided by the partners), including graphical information about the forex companies, brokers and dealing desks, is intended solely for informational purposes, is not a means of advertising them, and doesn't imply direct instructions for investing. Forex Ratings shall not be liable for any loss, including unlimited loss of funds, which may arise directly or indirectly from the usage of this information. The editorial staff of the website does not bear any responsibility whatsoever for the content of the comments or reviews made by the site users about the forex companies. The entire responsibility for the contents rests with the commentators. Reprint of the materials is available only with the permission of the editorial staff.
We use cookies to improve your experience and to make your stay with us more comfortable. By using Forex-Ratings.com website you agree to the cookies policy.